RE:Prices 4.1 million at $4 --huge huge discountWe need positive news to move the needle on this one even though the company (or investment firm)suggested that a phase 2 company should be traded at a much higher than current valuation.
Oh, and pricing at low end of range ... what a momentum killer!
And as for lack of US volume.. maybe company’s investment brokers went home for the weekend or maybe they are working on aligning everyone’s orders first since it’s such awesome deal. ;-)
Dead money until news.
My guess. Early first quarter with the Chinese starting their registered trial and DMA collecting that extra 4.5 million payment
cheees. JL